Patents Assigned to ALFACT INNOVATION
  • Patent number: 9629896
    Abstract: The invention relates to a HIP/PAP protein or to one of the derivatives thereof for use thereof for treating or preventing insulin resistance in non-insulin dependent subjects.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: April 25, 2017
    Assignees: ALFACT INNOVATION, INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS SUD, UNIVERSITE PARIS DIDEROT—PARIS 7
    Inventors: Fabrizio Andreelli, Paul Amouyal, Christophe Magnan, Celine Cruciani-Guglielmacci, Jamila Vaivre, Marion Darnaud, Laure Jamot, Christian Brechot, Gilles Amouyal
  • Patent number: 9474783
    Abstract: This invention concerns a HIP/PAP protein or derivative thereof, for its use in treating or managing cancer and preferentially solid tumors.
    Type: Grant
    Filed: July 18, 2013
    Date of Patent: October 25, 2016
    Assignees: ALFACT INNOVATION, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS SUD
    Inventors: Jamila Faivre, Eric Vibert, Marion Darnaud, Laure Jamot, Christian Brechot, Paul Amouyal, Gilles Amouyal
  • Publication number: 20120142604
    Abstract: The use of the HIP/PAP protein or a protein derivative thereof for manufacturing a medicament for preventing or treating: a neonatal brain injury, which includes a neonatal brain injury caused by a brain hypoxia, an adult or child brain injury, which includes an adult or child brain injury caused by a brain hypoxia, an adult or child or neonatal traumatic brain injury, a cerebellar disease or disorder, and a disease involving a defect in the production or in the phosphorylation of Gap-43.
    Type: Application
    Filed: June 11, 2010
    Publication date: June 7, 2012
    Applicant: ALFACT INNOVATION
    Inventors: Jamila Faivre, Pierre Gressens, Gilles Amouyal, Paul Amouyal, Christian Brechot, Elodie Rougier